FindTrial
Sign In

A study to find out if manual therapy and low-load strength training can reduce shoulder pain and improve movement in people who developed shoulder problems after COVID-19 vaccination.

Effectiveness of Integrative PhysiOsteopathic Therapy Combined with Blood Flow Restriction Training for Shoulder Dysfunction Following COVID-19 Vaccination: A Randomized Controlled Trial in the Post-Pandemic Era - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094398
Enrollment
60
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Physio-Osteopathic Therapy Combined with Blood Flow Restriction Training: Duration of Intervention: 8 weeks. Participants in the experimental group will receive a combined rehabilitatio

Sponsors

Dr Ramesh Chandra Patra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants eligible for the study will be adults aged between 20 and 50 years who develop shoulder pain within 4 weeks following COVID-19 vaccination. Clinical examination must reveal one or more of the following: supraspinatus tendinosis, posterior capsule tightness, pectoralis minor tightness, or cervical involvement such as sternocleidomastoid or upper trapezius hypertonicity. All participants must be willing and able to provide written informed consent prior to enrollment in the study.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they have a history of prior shoulder surgery on the affected side or have experienced severe shoulder or cervical trauma. Individuals with neurological disorders affecting the upper limb will also be excluded, as will those with contraindications to Blood Flow Restriction Training (BFRT), including vascular disorders, uncontrolled hypertension, or clotting disorders. Pregnant or breastfeeding women will not be eligible to participate in the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the intensity of shoulder pain, which will be assessed using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS) at 8 weeks post-intervention. This measure will provide a quantitative assessment of pain reduction and serve as the main indicator of the effectiveness of the integrative Physio-Osteopathic therapy combined with Blood Flow Restriction Training compared to standard physiotherapy care.Timepoint: Baseline Assessment, 8 weeks, and 12 weeks follow-up—

Secondary

MeasureTime frame
Shoulder and cervical range of motion, functional disability (DASH or SPADI), muscle strength of rotator cuff and scapular stabilizers, quality of life (SF-36 or EQ-5D), sleep quality (PSQI), and patient satisfaction.Timepoint: Baseline Assessment, 8 weeks, and 12 weeks follow-up—

Countries

India

Contacts

Public ContactDr Ramesh Chandra Patra

Lovely Professional University Faculty of Applied Medical Sciences

rafiqsarfroz@gmail.com09653174563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026